BRIEF published on 05/16/2025 at 15:35, 1 year 3 months ago The Vanguard Group Discloses Position in LondonMetric Property plc Securities Form 8.3 Takeover Code Vanguard Group LondonMetric Property
PRESS RELEASE published on 05/16/2025 at 15:33, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Assura plc The Vanguard Group, Inc. discloses a 5.66% interest in Assura plc's 10p ordinary shares. Additionally, disclosures related to Primary Health Properties plc The Vanguard Group, Assura Plc, Disclosure, Interest, Shares
PRESS RELEASE published on 05/16/2025 at 15:32, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Aviva plc The Vanguard Group, Inc. discloses a 5.19% interest in Aviva plc as of 15 May 2025. Additional disclosures include dealings with Direct Line Insurance Group plc Disclosure The Vanguard Group Dealings Direct Line Insurance Group Aviva Plc
PRESS RELEASE published on 05/16/2025 at 15:31, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Life Science REIT plc The Vanguard Group, Inc. discloses a 0.99% ownership in Life Science REIT plc. Details on securities and dealings per Form 8.3 Securities Vanguard Group Ownership Disclosure Dealings Life Science REIT Plc
PRESS RELEASE published on 05/16/2025 at 15:30, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: PRS REIT plc, The The Vanguard Group, Inc. discloses 1.75% ownership in PRS REIT plc, The. Disclosure includes interests in 1p ordinary securities The Vanguard Group Ownership Disclosure Interests 1p Ordinary Securities PRS REIT Plc
PRESS RELEASE published on 05/16/2025 at 15:30, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. discloses 5.08% interest in LondonMetric Property plc as of 15 May 2025. Additional disclosure on Urban Logistics REIT plc made Securities Disclosure Vanguard Group LondonMetric Property Urban Logistics REIT
BRIEF published on 05/15/2025 at 16:30, 1 year 3 months ago The Vanguard Group Discloses Position in LondonMetric Property Form 8.3 Position Disclosure Takeover Code Vanguard Group LondonMetric Property
BRIEF published on 05/15/2025 at 16:27, 1 year 3 months ago Vanguard Group Discloses Stake in Bakkavor Group Form 8.3 Takeover Code Vanguard Group Stake Disclosure Bakkavor Group
PRESS RELEASE published on 05/15/2025 at 16:25, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. discloses a 5.09% stake in LondonMetric Property plc. Details of positions, dealings, and disclosures in compliance with Rule 8.3 of the Takeover Code LondonMetric Property Plc Rule 8.3 Takeover Code Vanguard Group Stake Disclosure
BRIEF published on 05/15/2025 at 16:24, 1 year 3 months ago The Vanguard Group Discloses Stake in Dowlais Group plc Form 8.3 Takeover Code Vanguard Group Stake Disclosure Dowlais Group
Published on 09/11/2026 at 04:00, 5 hours 7 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 10 hours 42 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 17 hours 47 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 7 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 08:15, 51 minutes ago EQS-Adhoc: Airbus SE: Airbus commences limited share buyback to support future employee share ownership plan activities and equity-based compensation
Published on 09/11/2026 at 08:02, 1 hour 4 minutes ago PUMA CCO Matthias Baeumer to step down from Management Board
Published on 09/11/2026 at 07:30, 1 hour 36 minutes ago NAGRAVISION and MediaTek Broaden Partnership to Redefine Content Security for Premium Content on Connected TVs
Published on 09/11/2026 at 07:00, 2 hours 7 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 13 hours 37 minutes ago Availability of the 2026 Interim Financial Report
